Toshiyuki Harada

Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR

Makoto Maemondo, Akira Inoue, Kunihiko Kobayashi et al. · New England Journal of Medicine · 2010 · 5.5K citations

Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)

Akira Inoue, Kunihiko Kobayashi, Makoto Maemondo et al. · Annals of Oncology · 2012 · 549 citations

Oncology, Pathology, Cancer Treatment +6

Gefitinib Alone Versus Gefitinib Plus Chemotherapy for Non–Small-Cell Lung Cancer With Mutated Epidermal Growth Factor Receptor: NEJ009 Study

Yukio Hosomi, Satoshi Morita, Shunichi Sugawara et al. · Journal of Clinical Oncology · 2019 · 473 citations

Feasibility of insertion/implantation of 2.0-mm-diameter gold internal fiducial markers for precise setup and real-time tumor tracking in radiotherapy

Hiroki Shirato, Toshiyuki Harada, Tooru Harabayashi et al. · International Journal of Radiation Oncology*Biology*Physics · 2003 · 347 citations

Real-time Tumor, Engineering, Oncologic Imaging +10

Insertion and fixation of fiducial markers for setup and tracking of lung tumors in radiotherapy

Mikado Imura, Koichi Yamazaki, Hiroki Shirato et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 174 citations

Adaptive Radiotherapy, Lung Tumors, Medical Imaging +10